EN
HI
Zenotech Laboratories share price chart
Zenotech Laboratories Share Key Metrics
Volume
0.00
Market Cap
277.69 CR
LTQ@LTP
0@45.50
ATP
0
Var Margin
25 %
Circuit Range
36.4-54.6
Delivery %
90.33 %
Value
0.00
ASM/GSM
No
Market Lot
1
Summary
ZENOTECH stock price is ₹45.5 as of 25 Aug, 2026. The stock intraday movement has stayed between ₹0.00 and ₹0.00, while Zenotech Laboratories share price 52 week high low is ₹33.55 & ₹57.90.
In terms of trading activity, ZENOTECH share price has recorded a volume of 0 shares. The Zenotech Laboratories has a market cap of ₹61030568. The stock’s Average Traded Price (ATP) stands at ₹0.00, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 0 @ ₹45.50.
The Zenotech Laboratories upper circuit limit is ₹54.60 & The Zenotech Laboratories lower circuit limit is ₹36.40, with a Value of ₹0.00. The Delivery Percentage for the day is 90.33%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Zenotech Laboratories Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.22
Sector P/B
3.36
Sec. Div. Yield
0.51
Zenotech Laboratories Resistance and Support
Pivot 45.73
Resistance
First Resistance
46.46
Second Resistance
47.42
Third Resistance
48.15
Support
First Support
44.77
Second Support
44.04
Third Support
43.08
Zenotech Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 24 2026 | 45.5 | 45.5 | -1.62% | 46.68 | 45 |
| Fri Aug 21 2026 | 46.97 | 46.25 | 0.96% | 46.97 | 45 |
| Thu Aug 20 2026 | 47 | 45.81 | -1.34% | 47 | 45.15 |
Zenotech Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-28 | Quarterly Results |
| 2026-04-29 | Audited Results |
| 2026-01-23 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-04-25 | Audited Results |
| 2025-01-28 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
Zenotech Laboratories News
Zenotech Laboratories Ltd - 532039 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today, I.E., July 28, 2026
Zenotech Laboratories Board approved Q1 FY27 standalone financial results, reporting a net loss of ₹45.55 lakhs for the quarter ended June 30, 2026. The company also approved convening its 37th Annual General Meeting on September 25, 2026, through videoconferencing.
Jul 28 2026 14:47:27
Zenotech Laboratories Management
| Name | Position |
|---|---|
| Abdul Gafoor Mohammad | Company Secretary & Compliance Officer |
| Azadar Hussain Khan | Non Independent & Non Executive Director |
Zenotech Laboratories Similar Stocks
Zenotech Laboratories FAQs
The Buying Price of Zenotech Laboratories share is 45.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zenotech Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zenotech Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zenotech Laboratories shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zenotech Laboratories shares is 0. Useful to assess the stock's value relative to its book value.
To assess Zenotech Laboratories’s valuation compare Sector P/E, P/B which are 69.22 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zenotech Laboratories is 277.69 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zenotech Laboratories share price is 57.90 & 33.55. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zenotech Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
